Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment Response and Drug Resistance Profiling of Genotype 6 of Hepatitis C Virus in HCV/HIV Co-Infected Patients: A Pilot Study from INDIA.

Viruses - 30 Apr 2022

Gupta Ekta, Samal Jasmine, Pandey Amit, Singh Gaurav, Gupta Hajra A S, Agarwal Reshu, Sharma Manoj Kumar

Abstract excerpt

Hepatitis C Virus (HCV) genotype (GT) 6 demonstrates maximum genomic diversity out of all the known genotypes of HCV, attributable to its inherent intra-genotype and inter-genotype recombination property. This is the most common genotype seen in HCV/HIV co-infected cases. HIV/HCV co-infection is linked with increased genetic diversity in HCV structural genes. The detailed information on the distribution of HCV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coinfection
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Hepacivirus

Share to Hepatitis C

Share to HIV Infections

Share to Pilot Projects

Source

Open in PubMed Open full text

Identifiers

PMID: 35632686
DOI: 10.3390/v14050944
PMCID: PMC9146731

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment Response and Drug Resistance Profiling of Genotype 6 of Hepatitis C Virus in HCV/HIV Co-Infected Patients: A Pilot Study from INDIA.PMID 35632686Read ↗

Whole genome sequencing of Hepatitis C virus subtype 6xa and NS5A resistance mutations in a genotype 3b relapse case after direct-acting antiviral therapy in IndiaSemantic proximity Read ↗

Unraveling HCV Diversity and Resistance in Viet Nam: Implications for TreatmentSemantic proximity Read ↗

Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses.Semantic proximity Read ↗

Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.Semantic proximity Read ↗

Characterization of a Novel Hepatitis C Subtype, 6xj, and Its Consequences for Direct-Acting Antiviral Treatment in Yunnan, China.Semantic proximity Read ↗

Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents.Semantic proximity Read ↗

Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals.Semantic proximity Read ↗

'Unusual' HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment.Semantic proximity Read ↗

Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time.Semantic proximity Read ↗

Complete genome sequencing and phylogenetic analysis of HCV isolates from China reveals a new subtype, designated 6u.Semantic proximity Read ↗

HCV-genotypes: a review on their origin, global status, assay system, pathogenecity and response to treatment.Semantic proximity Read ↗

Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.